128 related articles for article (PubMed ID: 14646621)
1. Use of multiple cytometric markers improves discrimination between benign and malignant melanocytic lesions: a study of DNA microdensitometry, karyometry, argyrophilic staining of nucleolar organizer regions and MIB1-Ki67 immunoreactivity.
Li LX; Crotty KA; Scolyer RA; Thompson JF; Kril JJ; Palmer AA; McCarthy SW
Melanoma Res; 2003 Dec; 13(6):581-6. PubMed ID: 14646621
[TBL] [Abstract][Full Text] [Related]
2. Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis.
Li LX; Crotty KA; Palmer AA; Kril JJ; Stankovic R; Scolyer RA; McCarthy SW
Anal Quant Cytol Histol; 2002 Aug; 24(4):234-43. PubMed ID: 12199325
[TBL] [Abstract][Full Text] [Related]
3. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; Thompson JF; McCarthy SW
Am J Dermatopathol; 2003 Jun; 25(3):190-7. PubMed ID: 12775980
[TBL] [Abstract][Full Text] [Related]
4. A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions.
Li LX; Crotty KA; McCarthy SW; Palmer AA; Kril JJ
Am J Dermatopathol; 2000 Dec; 22(6):489-95. PubMed ID: 11190439
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organizer regions in melanocytic dysplasia and melanoma.
Fallowfield ME; Dodson AR; Cook MG
Histopathology; 1988 Jul; 13(1):95-9. PubMed ID: 3209193
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic impact of nuclear DNA content and proliferative activity in benign and malignant melanocytic lesions.
Steinbeck ZR; Heselmeyer KM; Gerlach B; Björnhagen V; Auer GU
Melanoma Res; 1996 Feb; 6(1):37-43. PubMed ID: 8640068
[TBL] [Abstract][Full Text] [Related]
7. Prognosing melanomas: the argyrophilic nucleolar organizer region approach.
Rebora A
Dermatology; 1992; 185(3):166-8. PubMed ID: 1446080
[TBL] [Abstract][Full Text] [Related]
8. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
Evans AT; Orrell JM; Grant A
J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
[TBL] [Abstract][Full Text] [Related]
9. An assessment of the value of Ag NOR staining in the identification of dysplastic and other borderline melanocytic naevi.
MacKie RM; White SI; Seywright MM; Young H
Br J Dermatol; 1989 Apr; 120(4):511-6. PubMed ID: 2471546
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
Reis JP; Tellechea O; Baptista AP
Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar organizer regions (AgNOR) and Ki-67 immunoreactivity in cutaneous melanocytic lesions.
Fogt F; Vortmeyer AO; Tahan SR
Am J Dermatopathol; 1995 Feb; 17(1):12-7. PubMed ID: 7695006
[TBL] [Abstract][Full Text] [Related]
12. [Value of nucleolus organizer regions (AgNORs) in dermatologic oncology].
Pfau A; Eckert F; Schröpfer T; Rüschoff J
Hautarzt; 1994 Nov; 45(11):762-8. PubMed ID: 7822200
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
14. The value of nucleolar organizer region staining in the differential diagnosis of borderline melanocytic lesions.
Fallowfield ME; Cook MG
Histopathology; 1989 Mar; 14(3):299-304. PubMed ID: 2468598
[TBL] [Abstract][Full Text] [Related]
15. Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores.
Dervan PA; Gilmartin LG; Loftus BM; Carney DN
Am J Clin Pathol; 1989 Oct; 92(4):401-7. PubMed ID: 2552790
[TBL] [Abstract][Full Text] [Related]
16. Discrimination between benign and malignant melanocytic skin lesions by multivariate analysis, quantitative S-100 immunohistochemistry, nuclear morphometry and DNA cytometry.
Williams RA; Rode J; Baak JP; Charlton IG
Anal Quant Cytol Histol; 1999 Aug; 21(4):353-7. PubMed ID: 10560514
[TBL] [Abstract][Full Text] [Related]
17. Nucleolar organizer regions in malignant melanoma and melanocytic nevi. Comparison of two counting methods.
Di Gregorio C; Losi L; Annessi G; Botticelli A
Am J Dermatopathol; 1991 Aug; 13(4):329-33. PubMed ID: 1928617
[TBL] [Abstract][Full Text] [Related]
18. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
Naik R; Raghuveer CV; Jacob DL
J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
[TBL] [Abstract][Full Text] [Related]
19. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
Orrell JM; Evans AT; Grant A
J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
[TBL] [Abstract][Full Text] [Related]
20. AgNOR (nucleolar organizer regions) staining in malignant melanoma.
Nagatani T; Iemoto G; Miyakawa K; Ichiyama S; Takahashi Y; Uchiyama M; Nakajima H
J Dermatol; 1991 Dec; 18(12):731-5. PubMed ID: 1806604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
